Link to this page
Medical Subject Headings
| Preferred Name | Rosiglitazone | |
| Synonyms |
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate Rosiglitazone Maleate BRL 49653 BRL49653 BRL-49653 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- Avandia |
|
| Definitions |
A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077154 |
|
| altLabel |
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate Rosiglitazone Maleate BRL 49653 BRL49653 BRL-49653 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)- Avandia
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C0795660 C0289314 C0289313 C0875967
|
|
| DC |
1
|
|
| definition |
A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.
|
|
| DX |
20190101
|
|
| FX |
D000077205
|
|
| HN |
2019 (1994)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
KX2339DP44 05V02F2KDG 0
|
|
| Inverse of RO | ||
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; ROSIGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1994-2003
|
|
| MDA |
20180709
|
|
| MMR |
20180702
|
|
| MN |
D02.886.675.933.500 D03.383.129.708.933.500
|
|
| notation |
D000077154
|
|
| PA |
D007004
|
|
| prefLabel |
Rosiglitazone
|
|
| RR |
KX2339DP44
|
|
| TERMUI |
T267203 T267205 T410157 T000937058 T267202 T000937060 T000937057
|
|
| TH |
US UK NLM (2000) CA FDA SRS (2017) NLM (1994) ES USAN (19XX) INN (19XX) DE AU FDA SRS (2015) FR IE
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |